2018-12884. Importer of Controlled Substances Registration

ACTION:

Notice of registration.

SUMMARY:

Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION:

The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

Company	FR citation	Published
Sharp Clinical Services, Inc	83 FR 13521	March 29, 2018.
Fisher Clinical Services, Inc	83 FR 13519	March 29, 2018.
Wildlife Laboratories Inc	83 FR 14505	April 4, 2018.
Catalent Pharma Solutions, LLC	83 FR 14504	April 4, 2018.
Lipomed	83 FR 15627	April 11, 2018.
Almac Clinical Services Incorp	(ACSI) 83 FR 15634	April 11, 2018.
Clinical Supplies Management Holdings, Inc	83 FR 16901	April 17, 2018.

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.

Dated: June 6, 2018.

John J. Martin,

Assistant Administrator.